F1 Pharma S.A.
PrivateLast Round
Grant
Dec 1, 2017
Total Funding Raised
$1.72M
Company Overview
F1 Pharma S.A. operates in Healthcare & Life Sciences and is based in Kraków. Its latest recorded funding round was a Grant round in December 2017.
F1 Pharma S.A. is a pharmaceutical company that provides research and development services, including analytical procedures, quality control, and regulatory support for the pharmaceutical industry.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
F1 Pharma S.A. Comparables
Compare F1 Pharma S.A. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Anapharm Bioanalytics | 79% | |
| QbD Group | 73% | |
| Selvita | 72% |
For institutional investors. Book with your work email.
F1 Pharma S.A. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 1, 2017 | ||||
| Grant | Apr 11, 2013 | ||||
| Seed | Oct 19, 2010 |
For institutional investors. Book with your work email.
F1 Pharma S.A. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Małopolskie Centrum Przedsiębiorczości | Grant |
| Jagiellońskie Centrum Innowacji | Seed |
| European Union | Grant |
| National Centre for Research and Development | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 20, 2026
Monthly visitors increased 162% MoM, reaching 212.
- Dec 1, 2017
$280K grant received from National Centre for Research and Development.
For institutional investors. Book with your work email.
F1 Pharma S.A. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about F1 Pharma S.A.'s valuation, stock price, and market status.
Is F1 Pharma S.A. a public or private company?
F1 Pharma S.A. is a private company.
What is the current stock price of F1 Pharma S.A.?
F1 Pharma S.A. is a private company, so its shares have no public market price. Caplight tracks F1 Pharma S.A.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is F1 Pharma S.A. worth (valuation)?
Valuation information for F1 Pharma S.A. is not publicly available.
Can I buy F1 Pharma S.A. stock?
F1 Pharma S.A. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was F1 Pharma S.A.'s last funding round?
F1 Pharma S.A.'s most recent funding round was Grant on December 1, 2017.
Who are the main investors in F1 Pharma S.A.?
Key investors in F1 Pharma S.A. include Małopolskie Centrum Przedsiębiorczości, Jagiellońskie Centrum Innowacji, European Union, National Centre for Research and Development.
Will F1 Pharma S.A. IPO soon?
No public IPO plans have been announced for F1 Pharma S.A..
How can I track F1 Pharma S.A. secondary market activity?
Caplight tracks bids, offers, and trades in F1 Pharma S.A.'s shares on secondary markets.